Skip to main content
. 2021 Nov 2;2021:4791915. doi: 10.1155/2021/4791915

Table 4.

Clinical characteristics of males and females according to studied groups.

Parameters Males Females
HL OND OD p value HL OND OD p value
N (M/F) 41 46 40 44 54 55
Age (years) 40.8 ± 14.3 41.8 ± 12.4B 49.1 ± 12.4A 0.009 37.0 ± 13.2 37.7 ± 4.5B 49.9 ± 8.9A <0.001
BMI (kg/m2) 22.0 ± 2.2 35.5 ± 4.5A 34.2 ± 3.3A <0.001 22.2 ± 2.1 36.2 ± 4.5A 34.8 ± 3.9A <0.001
WHR 0.95 ± 0.12 0.94 ± 0.10B 1.02 ± 0.11 0.03 0.83 ± 0.1 0.85 ± 0.10B 0.90 ± 0.10A 0.004
SBP (mmHg) 116.4 ± 10.3 126.2 ± 11.5A 129.5 ± 11.8A <0.001 111.3 ± 14.6 117.8 ± 9.6AB 128.8 ± 11.8A <0.001
DBP (mmHg) 76.9 ± 6.4 81.1 ± 5.8A 82.4 ± 7.5A 0.002 71.7 ± 5.8 76.3 ± 5.6AB 81.4 ± 6.4A <0.001
Glucose (nmol/L) 4.7 ± 0.6 4.8 ± 0.6B 10.9 ± 3.2A <0.001 4.7 ± 0.6 4.9 ± 0.4B 11.8 ± 3.8A <0.001
TC (nmol/L) 4.8 ± 1.0 5.1 ± 1.3 5.5 ± 1.8 0.08 4.6 ± 0.9 4.8 ± 0.9B 5.5 ± 1.4A <0.001
HDL (nmol/L) 0.99 ± 0.3 0.89 ± 0.2 0.86 ± 0.3 0.09 1.2 ± 0.3 1.1 ± 0.3 1.0 ± 0.3A <0.001
TG (nmol/L) 1.5 (1.1-2.0) 2.0 (1.2-2.6)B 2.5 (1.8-3.9)A <0.001 1.0 (0.8-1.2) 1.4 (1-1.8)AB 2.0 (1.5-3.1)A <0.001
Insulin (μIU/mL) 4.1 (2.3-6.3) 9.9 (7-17.2)AB 17.5 (8-49)A <0.001 3.0 (1.8-7.4) 7.3 (4-12)AB 12.0 (6-4)A <0.001
HOMA-IR 0.82 (0.4-1.4) 2.3 (1.2-3.8)AB 8.8 (4-22)A <0.001 0.7 (0.4-1.6) 1.5 (0.8-2.4)B 6.4 (2.6-13)A <0.001
PLIN3 (ng/mL) 10.6 (2.2-43.6) 5.2 (0.9-35.2) 3.4 (0.9-17.6) 0.14 25.9 (9.5-36.6) 20 (7-27)B 9.7 (2.2-25)A 0.007

Note: data presented as mean ± SD for normal and median (interquartile range for nonnormal variables). Superscript “ indicates significant difference from HL, and superscript “B” indicates significance compared to OND. Significant at p < 0.05. BMI: body mass index; BP: blood pressure; DBP: diastolic blood pressure; HDL: high-density lipoprotein; HOMA-IR: homeostasis insulin resistance; TC: total cholesterol; TG: triglycerides; WHR: waist-hip ratio.